Literature DB >> 22999255

Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance.

Chao Zhang1, Adam Huys, Patricia A Thibault, Joyce A Wilson.   

Abstract

MicroRNA-122 (miR-122) promotes Hepatitis C Virus (HCV) RNA stability, accumulation, and translation through hybridization with the 5' untranslated region (5' UTR) of the HCV genome. Depletion of Dicer and TRBP, proteins involved in miRNA biogenesis, reduced HCV RNA accumulation, mature duplex miR-122 abundance, and miR-122 directed mRNA translation suppression, suggesting roles in miR-122 processing. HCV RNA accumulation independent of endogenous mature duplex miR-122 was not affected by Dicer knockdown, suggesting that Dicer is required solely for miR-122 biogenesis, but TRBP knockdown reduced HCV RNA accumulation in this system, suggesting an additional role in supporting HCV RNA accumulation. Mature duplex miR-122 and pre-miR-122 hairpin, but not single-stranded miR-122 (guide or * strand), augmented HCV RNA accumulation and translation, and Dicer and TRBP were essential for the activity of pre-miR-122 in mouse fibroblasts. Thus, canonical miRNA processing and strand selection is essential for the activity of miR-122 on HCV translation and RNA accumulation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22999255     DOI: 10.1016/j.virol.2012.08.039

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

1.  HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.

Authors:  Sylvanne M Daniels; Lucile Sinck; Natalie J Ward; Carlos E Melendez-Peña; Robert J Scarborough; Ibrahim Azar; Elodie Rance; Aïcha Daher; Ka-Ming Pang; John J Rossi; Anne Gatignol
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 2.  Interaction of host cell microRNAs with the HCV RNA genome during infection of liver cells.

Authors:  Cecilia D Sedano; Peter Sarnow
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

3.  miR-122 and Ago interactions with the HCV genome alter the structure of the viral 5' terminus.

Authors:  Jasmin Chahal; Luca F R Gebert; Hin Hark Gan; Edna Camacho; Kristin C Gunsalus; Ian J MacRae; Selena M Sagan
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

4.  Regulation of Hepatitis C Virus Genome Replication by Xrn1 and MicroRNA-122 Binding to Individual Sites in the 5' Untranslated Region.

Authors:  Patricia A Thibault; Adam Huys; Yalena Amador-Cañizares; Julie E Gailius; Dayna E Pinel; Joyce A Wilson
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

5.  Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance.

Authors:  Jingmei Ye; Jiani Wang; Li Tan; Shaojiang Yang; Lihua Xu; Xiaohong Wu; Huaifu Deng; Huo Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 6.  The Interplay between the RNA Decay and Translation Machinery in Eukaryotes.

Authors:  Adam M Heck; Jeffrey Wilusz
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 7.  Role of circulatory microRNAs in the pathogenesis of hepatitis C virus.

Authors:  Iqra Almas; Samia Afzal; Muhammad Idrees; Muhammad Usman Ashraf; Iram Amin; Muhammad Shahid; Khadija Zahid; Sadia Zahid
Journal:  Virusdisease       Date:  2017-11-27

Review 8.  Hepatitis C virus infection, microRNA and liver disease progression.

Authors:  Shubham Shrivastava; Anupam Mukherjee; Ratna B Ray
Journal:  World J Hepatol       Date:  2013-09-27

9.  Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction.

Authors:  Selena M Sagan; Peter Sarnow; Joyce A Wilson
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  miR-122 and the Hepatitis C RNA genome: more than just stability.

Authors:  You Li; Takahiro Masaki; Stanley M Lemon
Journal:  RNA Biol       Date:  2013-05-22       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.